Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 42 articles:
HTML format

Single Articles

    January 2021
  1. MOGHADDAM N, Swiston JR, Tsang MY, Levy R, et al
    Am Heart J. 2021 Jan 7. pii: S0002-8703(21)00005.
    PubMed     Abstract available

    December 2020
  2. MILLS KT, Peacock E, Chen J, Zimmerman A, et al
    Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS): Rationale and design of a cluster-randomized trial.
    Am Heart J. 2020;230:13-24.
    PubMed     Abstract available

    October 2020
  3. NOWAK RM, Jacobsen G, Jr AL, Peacock WF, et al
    Outpatient versus Observation/Inpatient Management of Emergency Department Patients Rapidly Ruled-out for Acute Myocardial Infarction: Findings from the HIGH-US Study.
    Am Heart J. 2020 Oct 27. pii: S0002-8703(20)30353.
    PubMed     Abstract available

  4. CHOW CK, Atkins ER, Billot L, Chalmers J, et al
    Ultra-low-dose quadruple combination blood pressure lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
    Am Heart J. 2020 Oct 2. pii: S0002-8703(20)30273.
    PubMed     Abstract available

    August 2020
  5. OREN O, Gersh BJ, Blumenthal RS
    Anticipating and curtailing the cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19.
    Am Heart J. 2020;226:1-3.

    July 2020
  6. MEIJS TA, Krings GJ, Saad A, Molenschot MMC, et al
    Epinephrine stress testing during cardiac catheterization in patients with aortic coarctation.
    Am Heart J. 2020;225:78-87.
    PubMed     Abstract available

    May 2020
  7. COOPER LA, Marsteller JA, Carson KA, Dietz KB, et al
    Trial design of the RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs health system plus a collaborative/stepped care intervention to reduce hypertension disparities.
    Am Heart J. 2020;226:94-113.
    PubMed     Abstract available

    April 2020
  8. AESCHBACHER S, Mongiat M, Bernasconi R, Blum S, et al
    Aldosterone-to-renin ratio and blood pressure in young adults from the general population.
    Am Heart J. 2020;222:199-207.
    PubMed     Abstract available

    March 2020
  9. HUANG L, Tian M, Yu J, Li Q, et al
    Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS).
    Am Heart J. 2020;221:136-145.
    PubMed     Abstract available

    February 2020
  10. HAFF N, Lauffenburger JC, Morawski K, Ghazinouri R, et al
    The accuracy of self-reported blood pressure in the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial: Implications for pragmatic trials.
    Am Heart J. 2020;220:68-72.
    PubMed     Abstract available

    November 2019
  11. LORING Z, Shrader P, Allen LA, Blanco R, et al
    Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
    Am Heart J. 2019;219:21-30.
    PubMed     Abstract available

    July 2019
  12. OKEKE NL, Webel AR, Bosworth HB, Aifah A, et al
    Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD).
    Am Heart J. 2019;216:91-101.
    PubMed     Abstract available

    June 2019
  13. JOSHI R, Agrawal T, Fathima F, Usha T, et al
    Cardiovascular risk factor reduction by community health workers in rural India: A cluster randomized trial.
    Am Heart J. 2019;216:9-19.
    PubMed     Abstract available

    April 2019
  14. SULLIVAN LT 2ND, Mulder H, Chiswell K, Shaw LK, et al
    Racial differences in long-term outcomes among black and white patients with drug-eluting stents.
    Am Heart J. 2019;214:46-53.
    PubMed     Abstract available

    November 2018
  15. GEENEN LW, Baggen VJM, Koudstaal T, Boomars KA, et al
    The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.
    Am Heart J. 2018;208:91-99.
    PubMed     Abstract available

    October 2018
  16. DAVISON WJ, Myint PK, Clark AB, Potter JF, et al
    Blood pressure differences between home monitoring and daytime ambulatory values and their reproducibility in treated hypertensive stroke and TIA patients.
    Am Heart J. 2018;207:58-65.
    PubMed     Abstract available

    September 2018
  17. EYSENCK W, van Zalen J, Freemantle N, Lloyd G, et al
    Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension and paroxysmal AF.
    Am Heart J. 2018 Sep 29. pii: S0002-8703(18)30279.
    PubMed     Abstract available

    August 2018
  18. LOPES RD, Barroso WKS, Brandao AA, Barbosa ECD, et al
    The First Brazilian Registry of Hypertension.
    Am Heart J. 2018 Aug 30. pii: S0002-8703(18)30255.
    PubMed     Abstract available

  19. WHITE WB, Jalil F, Wakefield DB, Kaplan RF, et al
    Relationships among clinic, home, and ambulatory blood pressures with small vessel disease of the brain and functional status in older people with hypertension.
    Am Heart J. 2018;205:21-30.
    PubMed     Abstract available

  20. CLAUDEL SE, Adu-Brimpong J, Banks A, Ayers C, et al
    Association between neighborhood-level socioeconomic deprivation and incident hypertension: A longitudinal analysis of data from the Dallas heart study.
    Am Heart J. 2018;204:109-118.
    PubMed     Abstract available

    July 2018
  21. PAGIDIPATI NJ, Hellkamp AS, Sharma PP, Wang TY, et al
    High-sensitivity C-reactive protein elevation in patients with prior myocardial infarction in the United States.
    Am Heart J. 2018;204:151-155.
    PubMed     Abstract available

  22. ZWIJNENBURG RD, Baggen VJM, Geenen LW, Voigt KR, et al
    The prevalence of pulmonary arterial hypertension before and after atrial septal defect closure at adult age: A systematic review.
    Am Heart J. 2018;201:63-71.
    PubMed     Abstract available

    June 2018
  23. SCHWALM JR, McCready T, Lamelas P, Musa H, et al
    Rationale and design of a cluster randomized trial of a multifaceted intervention in people with hypertension: The Heart Outcomes Prevention and Evaluation 4 (HOPE-4) Study.
    Am Heart J. 2018;203:57-66.
    PubMed     Abstract available

    May 2018
  24. MUKHTAR O, Cheriyan J, Cockcroft JR, Collier D, et al
    A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in
    Am Heart J. 2018;204:102-108.
    PubMed     Abstract available

    January 2018
  25. MAURI L, Kario K, Basile J, Daemen J, et al
    A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
    Am Heart J. 2018;195:115-129.
    PubMed     Abstract available

    October 2017
  26. WAKSMAN R, Bakris GL, Steinvil A, Garcia-Garcia H, et al
    High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
    Am Heart J. 2017;192:76-84.
    PubMed     Abstract available

    July 2017
  27. AUSTIN C, Burger C, Kane G, Safford R, et al
    High-risk echocardiographic features predict mortality in pulmonary arterial hypertension.
    Am Heart J. 2017;189:167-176.
    PubMed     Abstract available

    June 2017
  28. NEAL B, Tian M, Li N, Elliott P, et al
    Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trial.
    Am Heart J. 2017;188:109-117.
    PubMed     Abstract available

    April 2017
  29. VEMULAPALLI S, Deng L, Patel MR, Kilgore ML, et al
    National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Am Heart J. 2017;186:29-39.
    PubMed     Abstract available

  30. MORAWSKI K, Ghazinouri R, Krumme A, McDonough J, et al
    Rationale and design of the Medication adherence Improvement Support App For Engagement-Blood Pressure (MedISAFE-BP) trial.
    Am Heart J. 2017;186:40-47.
    PubMed     Abstract available

    March 2017
  31. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    PubMed     Abstract available

  32. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Abstract available

  33. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Abstract available

  34. KHETAN A, Purushothaman R, Zullo M, Gupta R, et al
    Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India.
    Am Heart J. 2017;185:161-172.
    PubMed     Abstract available

    September 2016
  35. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    PubMed     Abstract available

  36. BHATNAGAR A, Bolli R, Johnstone BH, Traverse JH, et al
    Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
    Am Heart J. 2016;179:142-50.
    PubMed     Abstract available

  37. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Abstract available

    August 2016
  38. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    PubMed     Abstract available

  39. VEMULAPALLI S, Hellkamp AS, Jones WS, Piccini JP, et al
    Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial.
    Am Heart J. 2016;178:74-84.
    PubMed     Abstract available

  40. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    PubMed     Abstract available

  41. AKERBLOM A, Clare RM, Lokhnygina Y, Wallentin L, et al
    Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
    Am Heart J. 2016;178:1-8.
    PubMed     Abstract available

    July 2016
  42. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.